（文章来源：证券日报） 证券日报网讯 1月7日，新华医疗在互动平台回答投资者提问时表示，公司始终重视与机构投资者的沟 通交流，且通过多元化方式持续传递经营价值。 ...

Group 1 - The core viewpoint of the article is that Xinhua Medical (600587) is committed to timely disclosing the progress of its logistics and rehabilitation medical robotics development while ensuring compliance, highlighting the value of state-owned enterprise technological innovation and application in real-world scenarios [1] Group 2 - The company emphasizes its focus on transparency in reporting advancements in its medical robotics projects [1] - The initiative reflects the broader trend of state-owned enterprises in China prioritizing technological innovation [1] - The company aims to enhance the understanding of the practical applications of its technologies in the healthcare sector [1]

（编辑 丛可心） 证券日报网讯 1月7日，新华医疗在互动平台回答投资者提问时表示，山东健康集团已实施增持计划， 充分体现对公司长期发展的信心。股份回购需综合公司财务状况、研发与经营资金需求等多重因素，按 规则审慎决策。 ...

证券日报网讯1月7日，新华医疗（600587）在互动平台回答投资者提问时表示，采购国产优先政策有望 提升中标率与市场份额，具体受益金额受多重因素影响，公司将积极把握政策机遇，扩大市场份额。 ...

Group 1 - The core point of the article is that Xinhua Medical announced a capital increase of 60 million yuan for its subsidiary, Xinhua Medical Rehabilitation Industry (Xi'an) Co., Ltd., aimed at enhancing the research, production, and operational funding for rehabilitation equipment business [1] - The capital increase will primarily support the overall business development of rehabilitation equipment [1] - The announcement was made in response to investor inquiries on the company's interactive platform [1]

Group 1 - The company has significantly increased its R&D investment in recent years, focusing on fields such as radiotherapy, minimally invasive endoscopy, and rehabilitation intelligent devices [1] - The company has achieved phased breakthroughs, resulting in the registration of multiple new products and international certifications [1] - The core competitiveness of the company is steadily improving as a result of these efforts [1]

Core Viewpoint - Xinhua Medical (600587.SH) is developing humanoid robots for application in experimental animal centers, aimed at automating repetitive tasks such as animal care and cage transportation, contributing to the construction of unmanned animal research facilities [1] Group 1: Company Developments - The humanoid robot has entered the exploratory phase for application in experimental animal centers [1] - The development of the humanoid robot is intended to accumulate technological reserves for future smart experimental animal centers [1] - The robot will work in conjunction with existing automated systems, such as the fully automated cage handling system and robotic arms, to enhance the intelligence level of animal facilities [1]

Group 1 - The core viewpoint of the article is that Xinhua Medical (600587.SH) has announced that its rehabilitation product-related business will enter the industrialization phase by 2025 [1] - The company will focus on product promotion and market expansion [1] - Specific operational data will be provided in future announcements [1]

Group 1 - The core point of the article is that Xinhua Medical (600587.SH) has reported that its overseas sales of medical electronic linear accelerators have exceeded 200 million yuan [1] Group 2 - The company has actively engaged with investors through an interactive platform to share its sales achievements [1] - The reported sales figure indicates a significant milestone for the company in the international market [1] - This achievement may reflect the company's growth strategy and its focus on expanding its presence in overseas markets [1]

Core Viewpoint - Xinhua Medical (600587) plans to invest 60 million yuan of its own funds into its wholly-owned subsidiary, Xinhua Medical Rehabilitation Industry (Xi'an) Co., Ltd., to enhance its operational capacity and development capabilities [1] Group 1: Investment Details - The investment aims to supplement the working capital of the Xi'an Rehabilitation Company [1] - The funding will accelerate the research, production, and sales processes of rehabilitation equipment [1] - The company has established a solid industrial foundation through professional technical accumulation and precise market positioning [1] Group 2: Company Progress - Xinhua Medical Rehabilitation Company has made good progress in research and development, production, and sales [1] - The investment is intended to further expand the company's scale [1]